Alnylam Pharmaceuticals
Presença
Alnylam Pharmaceuticals é uma das ...
Alnylam Pharmaceuticals é uma empresa listada sob o símbolo ALNY (US).
Alnylam Pharmaceuticals tem presença direta em 2 países.
Executivos
Veja o organograma con seus 41 executivos principais
Biografias mais buscadas da Alnylam Pharmaceuticals
- Yvonne Greenstreet, Chief Executive Officer and Director
- Amy Schulman, Chairman of the Board
- Carolyn Bertozzi, Director
Recentes movimentos de executivos em Alnylam Pharmaceuticals
- Marsha Fanucci, Director, deixou a Companhia (Notícia publicada em 29 de setembro de 2023).
Criar um alerta
para seguir os movimentos de executivos da Alnylam Pharmaceuticals.
Biotecnologia
Alnylam Pharmaceuticals possui 2.275 concorrentes concorrentes Eurofins (Luxemburgo), Lonza (Suíça) e Adaptive Phage Therapeutics (Estados Unidos).
Popular M&A news in Biotecnologia
- Histogen has filed for bankruptcy protection (publicado em 19 de abril de 2024).
- Bruker has announced the acquisition of NanoString Technologies (publicado em 18 de abril de 2024).
- Vertex Pharmaceuticals has announced the acquisition of Alpine Immune Sciences (publicado em 16 de abril de 2024).
Outros contatos sugeridos na indústria do Biotecnologia
Notícias
Últimos comunicados de imprensa de Alnylam Pharmaceuticals
- Alnylam Presents Positive Results from the KARDIA-2 Phase 2 Study of Zilebesiran Added to Standard of Care Ant
- Alnylam Launches Hereditary ATTR (hATTR) Amyloidosis Campaign to Help Shorten Time to Diagnosis for Inherited
- Alnylam to Webcast Investor Event to Discuss Results from KARDIA-2 Phase 2 Study of Zilebesiran at American Co
- Alnylam Reports Positive KARDIA-2 Topline Study Results Demonstrating Clinically Significant Blood Pressure Re
- Alnylam to Webcast Presentations at Upcoming March Investor Conferences
- First Set of Recommendations Advocating for the Holistic Care of People Living with hATTR Amyloidosis Develope
- Alnylam to Appeal Claim Construction Ruling on Two Patents Asserted Against Moderna
- Alnylam to Webcast Presentation at Canaccord Genuity 43rd Annual Growth Conference
- Alnylam Pharmaceuticals Reports Second Quarter 2023 Financial Results and Highlights Recent Period Activity
- Alnylam to Webcast Conference Call Discussing Second Quarter 2023 Financial Results
- View more press releases Close
Redes sociais sobre Alnylam Pharmaceuticals
- Alnylam Pharmaceuticals na Wikipedia, Google News e Yahoo Finance
- Alnylam Pharmaceuticals na LinkedIn, Twitter e YouTube
Entrar em contato
Contate seus executivos por e-mail agora, incluindo Yvonne Greenstreet 
Ligue para a Alnylam Pharmaceuticals em +1 617...
